Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital

J Korean Med Sci. 2011 Oct;26(10):1258-64. doi: 10.3346/jkms.2011.26.10.1258. Epub 2011 Oct 1.

Abstract

In order to investigate the incidence, clinical and microbiologic characteristics of Clostridium difficile infection (CDI) in Korea, a prospective observational study was performed. From September 2008 through January 2010, all patients whose stool was tested for toxin assay A&B and/or C. difficile culture were studied for clinical characteristics. Toxin types of the isolates from stool were tested. The mean incidence of CDI per 100,000 patient-days was 71.6 by month (range, 52.5-114.0), and the ratio of CDI to antibiotic-associated diarrhea was 0.23. Among 200 CDI patients, 37.5% (75/200) was severe CDI based on severity score. Clinical outcome of 189 CDI was as followed; 25.9% (49/189) improved without treatment, 84.3% (118/140) achieved clinical cure and attributed mortality was 0.7% (1/140) with the treatment. Recurrence rate was 21.4% (30/140) and cure without recurrence was 66.4% (93/140). The most common type of toxin was toxin A-positive/toxin B-positive strain (77.5%), toxin A-negative/toxin B-positive strains or binary toxin-producing strains comprised 15.4% or 7.1%, respectively. In conclusion, the incidence of CDI in Korea is a little higher than other reports during the non-epidemic setting. We expect that the change of epidemiology and clinical severity in CDI can be evaluated based on these results.

Keywords: Clinical Characteristics; Clostridium difficile Infection; Incidence; Toxin Type.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Bacterial Proteins / analysis
  • Bacterial Toxins / analysis
  • Clostridioides difficile / isolation & purification*
  • Clostridioides difficile / pathogenicity*
  • Clostridium Infections / epidemiology*
  • Clostridium Infections / physiopathology
  • Diarrhea / epidemiology
  • Diarrhea / microbiology
  • Enterocolitis, Pseudomembranous / epidemiology*
  • Enterocolitis, Pseudomembranous / microbiology
  • Enterocolitis, Pseudomembranous / pathology
  • Enterotoxins / analysis
  • Feces / microbiology
  • Female
  • Hospitals
  • Humans
  • Incidence
  • Male
  • Metronidazole / therapeutic use
  • Middle Aged
  • Prospective Studies
  • Recurrence
  • Republic of Korea / epidemiology
  • Treatment Outcome
  • Vancomycin / therapeutic use

Substances

  • Bacterial Proteins
  • Bacterial Toxins
  • Enterotoxins
  • tcdA protein, Clostridium difficile
  • toxB protein, Clostridium difficile
  • Metronidazole
  • Vancomycin